4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-024519
EVP, Drug Development gave up 2,012 shares (to pay taxes)
- EVP, Drug Development acquired 5,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…